FDA Inspection 1006990 — Unetixs Vascular, Inc.

Unetixs Vascular, Inc. — FEI 1222117

The FDA completed an inspection of Unetixs Vascular, Inc. on March 29, 2017 in Warwick, RI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 14 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 29, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Warwick, RI (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
319221 CFR 820.30(g)Design validation - user needs and intended uses
323121 CFR 820.70(i)Documentation of software validation
323221 CFR 820.72(a)Equipment suitability & capability
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
63021 CFR 803.17Lack of Written MDR Procedures